Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy
Schneider, V, Zhang, L, Bullinger, L, Rojewski, M, Hofmann, S, Wiesneth, M, Schrezenmeier, H, Götz, M, Botzenhardt, U, Barth, T F E, Döhner, K, Döhner, H, Greiner, JVolume:
28
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2014.116
Date:
August, 2014
File:
PDF, 764 KB
english, 2014